Latest Articles Page 154 of 341
-
Mini Review January 24, 2023
P.1-2
J Clin Path Lab Med: 5(1): 1-2
Reason for existence in the field of laboratory medicine.
Author(s): Edwin Agarwal
-
Mini Review January 27, 2023
P.1-2
J Clin Path Lab Med: 5(1): 1-2
Amyotrophic lateral sclerosis new molecular pathology pathways.
Author(s): Sandra Elizabeth
-
Perspective January 30, 2023
P.1-2
J Clin Path Lab Med: 5(1): 1-2
The changing sands of diagnosis in hematopathology: Anaplastic massive cell lymphoma.
Author(s): Hofman James
-
Opinion Article January 30, 2023
P.1-2
Immune Syst Disord J: 6(1): 1-2
Primary eosinophilia and miscellaneous entities associated with eosinophilia
Author(s): Benjamin Moore
-
Opinion Article January 30, 2023
P.1-2
Immune Syst Disord J: 6(1): 1-2
Impact of Stress on Immune system and in comprehensive allergic disease management
Author(s): Martin Felomen
-
Opinion Article January 27, 2023
P.1-2
Immune Syst Disord J: 6(1): 1-2
B-cell immunodeficiencies and Innate disorders of Immune System
Author(s): Xiaoxuan vinch
-
Mini Review January 25, 2023
P.1-2
Immune Syst Disord J: 6(1): 1-2
Chronic allergic inflammation and the exacerbation of allergic disorders
Author(s): Nawaaz Taher
-
Opinion Article January 24, 2023
P.1-2
Immune Syst Disord J: 6(1): 1-2
Allergen immunotherapy for Allergic Rhinitis
Author(s): Ashanty Melo
-
Opinion Article December 30, 2022
P.1-2
J Clin Oncol Cancer Res: 5(6): 1-2
Risk study utilising Medicare claims data: Initial and recurrent thromboembolic disease rates in individuals with and without cancer.
Author(s): Choi Sasha
-
Rapid Communication December 29, 2022
P.1-2
J Clin Oncol Cancer Res: 5(6): 1-2
An study of current chemotherapeutic methods for treating humans
Author(s): Peter Babo